"Clínica de Hematologia e Oncologia - consultas, exames, tratamentos de quimioterapia, implante de cateter PICC e atendimentos complementares de outras especialidades como Reumatologia e Radiologia Intervencionista."

During the past decade, Instituto Joinvilense de Hematologia e Oncologia Ltda - Centro de Hematologia e Oncologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto Joinvilense de Hematologia e Oncologia Ltda - Centro de Hematologia e Oncologia" are "Metastatic Castrate Sensitive Prostate Cancer" (1 trials) and "Relapsed or Refractory Multiple Myeloma" (1 trials). Many other conditions were trialed in "Instituto Joinvilense de Hematologia e Oncologia Ltda - Centro de Hematologia e Oncologia" in a lesser frequency.

Most popular intervention types in "Instituto Joinvilense de Hematologia e Oncologia Ltda - Centro de Hematologia e Oncologia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone acetate (AA)" (1 trials), "Bortezomib" (1 trials), "Carfilzomib" (1 trials), "Dexamethasone" (1 trials) and "Niraparib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Joinvilense de Hematologia e Oncologia Ltda - Centro de Hematologia e Oncologia" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Instituto Joinvilense de Hematologia e Oncologia Ltda - Centro de Hematologia e Oncologia". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Instituto Joinvilense de Hematologia e Oncologia Ltda - Centro de Hematologia e Oncologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Joinvilense de Hematologia e Oncologia Ltda - Centro de Hematologia e Oncologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".